María Cruz Rodríguez-Oroz
María Cruz Rodríguez-Oroz publishes mostly in Neurology, Cellular and Molecular Neuroscience and Neurology, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Genetic Neurodegenerative Diseases.
- World rank
- #76,905 of 7,710,434 ranked researchers
- Rank in Spain
- #931 of 204,306
- Works
- 215
- Citations
- 22k
- Citations per work
- 102.4
What does María Cruz Rodríguez-Oroz research?
María Cruz Rodríguez-Oroz's work is mostly in Medicine (62%), Neuroscience (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13462.1%
- Medicine13462.1%
- Life Sciences4621.2%
- Neuroscience4621.2%
- Everything else3616.7%
- 1Neurology57% of their works
- 2Cellular and Molecular Neuroscience11% of their works
- 3Neurology6% of their works
- 4Cognitive Neuroscience4% of their works
- 5Physiology3% of their works
- 6Psychiatry and Mental health3% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Genetic Neurodegenerative Diseases
- Transcranial Magnetic Stimulation Studies
- Botulinum Toxin and Related Neurological Disorders
- Parkinson's Disease and Spinal Disorders
- Dementia and Cognitive Impairment Research
- Neuroscience and Neuropharmacology Research
Which keywords describe María Cruz Rodríguez-Oroz's research?
The keywords of their largest research topics: Parkinson's Disease, Mitochondrial Dysfunction, Neurological Disorders, Deep Brain Stimulation, a-Synuclein, Neurodegeneration, Basal Ganglia and Subthalamic Nucleus.
- Synaptic Plasticity
- Mild Cognitive Impairment
- Dropped Head Syndrome
- Neurotoxins
- Transcranial Magnetic Stimulation
- Protein Aggregation
- Subthalamic Nucleus
- a-Synuclein
- Deep Brain Stimulation
- Mitochondrial Dysfunction
- Parkinson's Disease
- Neurological Disorders
- Neurodegeneration
- Basal Ganglia
- Huntington's Disease
- Transcranial Direct Current Stimulation
- Botulinum Toxin
- Camptocormia
- Alzheimer's Disease
- Neurotransmission
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Parkinson's Disease3133 topics
- Mitochondrial Dysfunction1892 topics
- Neurological Disorders1854 topics
- Deep Brain Stimulation1582 topics
- Neurodegeneration1551 topic
- a-Synuclein1551 topic
- Basal Ganglia1421 topic
- Subthalamic Nucleus1421 topic
- Huntington's Disease341 topic
- Protein Aggregation341 topic
- Transcranial Direct Current Stimulation251 topic
- Transcranial Magnetic Stimulation251 topic
- Botulinum Toxin171 topic
- Neurotoxins171 topic
- Camptocormia161 topic
- Dropped Head Syndrome161 topic
- Alzheimer's Disease121 topic
- Mild Cognitive Impairment121 topic
- Neurotransmission101 topic
- Synaptic Plasticity101 topic
Where does María Cruz Rodríguez-Oroz work?
María Cruz Rodríguez-Oroz's main affiliation in the publication record is Clinica Universidad de Navarra, Spain.
How many publications and citations does María Cruz Rodríguez-Oroz have?
OpenAlex counts 215 works and 22,025 citations for María Cruz Rodríguez-Oroz, an h-index of 65, ranking #76,905 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about María Cruz Rodríguez-Oroz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.